Mary Pinto
Nurse Practitioner · Wilmington, NCNPI 1073986360
Payments from drug & device makers
Across 90 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$361
- Pharmacosmos Therapeutics Inc.$226
- Novartis$193
- Merck$160
- Exelixis Inc.$157
- Bristol Myers Squibb$139
- plus $848 from 22 others
What the payments were for
- Food & beverage$1,98495%
- Education$995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 11 | $361 |
| Pharmacosmos Therapeutics Inc. | 9 | $226 |
| Novartis | 8 | $193 |
| Merck | 7 | $160 |
| Exelixis Inc. | 5 | $157 |
| Bristol Myers Squibb | 7 | $139 |
| Genentech USA, Inc. | 6 | $128 |
| Pfizer | 6 | $120 |
| Daiichi Sankyo Inc. | 3 | $70 |
| AstraZeneca(2 entities) | 3 | $63 |
| Astellas Pharma US Inc | 3 | $57 |
| Taiho Oncology, Inc. | 2 | $54 |
| Coherus Oncology, Inc. | 2 | $46 |
| Gilead | 2 | $39 |
| Amgen | 2 | $35 |
| Servier Pharmaceuticals LLC | 2 | $34 |
| UCB, Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $21 |
| Bayer | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| ADC Therapeutics America, Inc. | 1 | $13 |
| Foundation Medicine, Inc. | 1 | $13 |
How this compares
$2,083 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 48 | $1,307 |
| Letrozole | 42 | $915 |
| Tamoxifen Citrate | 21 | $666 |
| Oxycodone Hcl | 13 | $277 |
| Ibandronate Sodium | 11 | $162 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Wilmington
- Bridgette WilliamsWilmington$35K
- Kelly GlissonWilmington$30K
- Lauren GardnerWilmington$28K
- Michelle StoughWilmington$24K
- Edith SaffoWilmington$19K
- Rebecca MaphisWilmington$18K
- Breanna BrousseauWilmington$12K
- Anna PaylorWilmington$11K
- Sandrivette JohnsonRaleigh$573K
- Skyler RogersPinehurst$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.